Stay updated on Viatris Press Releases
Sign up to get notified when there's something new on the Viatris Press Releases page.

Latest updates to the Viatris Press Releases page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new press release dated May 18, 2026 about the FDA accepting Viatris' NDA for fast-acting meloxicam was added, and the February 26, 2026 financial results release was removed from the list.SummaryDifference7%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe Press Releases list has been updated with multiple May 2026 announcements (Bank of America conference, Q1 results, quarterly dividend, CFO transition, and related data presentations). Older items from February and January 2026 have been removed.SummaryDifference8%

- Check47 days agoChange DetectedAdded: Viatris to Report First Quarter 2026 Financial Results on May 7, 2026. Deleted: Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer (Jan 8, 2026).SummaryDifference6%

- Check54 days agoChange DetectedAdded a new press release entry for Apr 10, 2026 about multiple data presentations at the 2026 ASCRS Annual Meeting. Removed the Dec 18, 2025 press release about four regulatory milestones.SummaryDifference7%

- Check69 days agoChange DetectedAdded a new press release on Mar 23, 2026 about Effexor® approval in Japan for adults with GAD; removed the Dec 17, 2025 press release about presenting at the JP Morgan Healthcare Conference.SummaryDifference7%

- Check76 days agoChange DetectedA new press release entry dated Mar 19, 2026 was added to the Press Releases page; an older release about monetizing its Biocon Biologics stake was removed.SummaryDifference7%

Stay in the know with updates to Viatris Press Releases
Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.